Late-replicating heterochromatin is characterized by decreased cytosine methylation in the human genome.
about
Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AMLSystematic determination of replication activity type highlights interconnections between replication, chromatin structure and nuclear localization.Nanoscale changes in chromatin organization represent the initial steps of tumorigenesis: a transmission electron microscopy studyGenome-wide assays that identify and quantify modified cytosines in human disease studiesKidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.Post-conversion targeted capture of modified cytosines in mammalian and plant genomes.Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes.DNA methylation signatures for breast cancer classification and prognosisSMITE: an R/Bioconductor package that identifies network modules by integrating genomic and epigenomic informationHSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.The early-life social environment and DNA methylation.The chromatin backdrop of DNA replication: lessons from genetics and genome-scale analyses.Integrating and mining the chromatin landscape of cell-type specificity using self-organizing maps.Concise Review: Geminin-A Tale of Two Tails: DNA Replication and Transcriptional/Epigenetic Regulation in Stem Cells.How might epigenetic dysregulation in early embryonic life contribute to autism spectrum disorder?DNA demethylation by 5-aza-2'-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences.Unmasking risk loci: DNA methylation illuminates the biology of cancer predisposition: analyzing DNA methylation of transcriptional enhancers reveals missed regulatory links between cancer risk loci and genes.Selective modulation of local linkages between active transcription and oxidative demethylation activity shapes cardiomyocyte-specific gene-body epigenetic status in mice.
P2860
Q33868160-1F4722F5-9BA1-4901-9566-D7013F16A374Q34473836-90AB62D6-24AD-4DE7-BF94-CB0ACF0A3C69Q35120815-67EAA848-5E56-440C-AF3C-1393404174D6Q35187229-DBBCAE8D-B2DB-460E-9681-75E8510C6F0DQ35582141-E63CD7B8-7F70-4EE1-B3E2-3D5BA3925336Q35587949-B55814E6-49C4-4F64-8800-2E4A0EDAA241Q35651346-7A75A1E2-B2FE-437F-A49B-FD931994E6A1Q36245189-F6EADECD-981A-4DE8-8A3E-650699757B2CQ36252978-80F8F991-FB94-49BB-A890-6294ECE4FCECQ37602230-A2134EFF-710A-4320-9838-C7C46132BFC6Q37974947-FBD3ED77-7959-42AF-9A94-EF57B53FB1FFQ37985257-55E23113-7521-4337-A246-408CBF2042B3Q38483993-6CD4CB03-E408-490D-8C8F-A3E9E1318FEEQ39012400-27DBCA35-4BE0-4B7C-8999-44578B3C5E21Q40709670-9C649983-4D73-4E87-8435-B765CED23811Q41167372-EA86ED74-2AE9-4251-AA19-17DAC3EFB262Q46241160-CC215716-26FC-49FC-A034-BFD3C6391810Q55236053-20BCDF7F-0396-4250-9A26-E8214A5FA250
P2860
Late-replicating heterochromatin is characterized by decreased cytosine methylation in the human genome.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Late-replicating heterochromat ...... thylation in the human genome.
@ast
Late-replicating heterochromat ...... thylation in the human genome.
@en
type
label
Late-replicating heterochromat ...... thylation in the human genome.
@ast
Late-replicating heterochromat ...... thylation in the human genome.
@en
prefLabel
Late-replicating heterochromat ...... thylation in the human genome.
@ast
Late-replicating heterochromat ...... thylation in the human genome.
@en
P2093
P2860
P50
P356
P1433
P1476
Late-replicating heterochromat ...... ethylation in the human genome
@en
P2093
Andrew S McLellan
Edyta Stasiek
Frederick Agyiri
Jacob L Glass
John A Stamatoyannopoulos
María-Paz Ramos
Masako Suzuki
Qiang Jing
R Scott Hansen
P2860
P304
P356
10.1101/GR.116509.110
P577
2011-09-28T00:00:00Z